Description

📄 Product Description:

Hertraz 440 mg is a Trastuzumab injection manufactured by Mylan, used for the treatment of HER2-positive breast cancer and metastatic gastric cancer. It is a monoclonal antibody that targets and blocks the HER2 receptor, helping to slow or stop the growth of cancer cells.

Administered through intravenous (IV) infusion, Hertraz is often used in combination with chemotherapy as part of a comprehensive cancer treatment plan. It is a trusted biosimilar of the original trastuzumab brand (Herceptin).

💉 Dosage & Administration:

• Strength: 440 mg per vial

• Route: Intravenous (IV) infusion

• Use under strict medical supervision only

⚠️ Important Information:

• Prescription drug – Schedule H

• May cause infusion reactions, fever, chills

• Regular heart function monitoring is required